A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes
NCT01467414
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class
Stopped
This trial was terminated due to low recruitment
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
insulin degludec
Sponsor
Novo Nordisk A/S